Expanding and improving nanobody repertoires using a yeast display method: Targeting SARS-CoV-2
Journal of Biological Chemistry · 2023
DOI: 10.1016/j.jbc.2023.102954 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Frederick R Cross und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cell Cycle Genetics, The Rockefeller University, New York, New York, USA. Electronic address: fcross@rockefeller.edu. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, SARS-CoV-2, Single-Domain Antibodies. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
COVID-19, caused by the coronavirus SARS-CoV-2, represents a serious worldwide health issue, with continually emerging new variants challenging current therapeutics. One promising alternate therapeutic avenue is represented by nanobodies, small single-chain antibodies derived from camelids with numerous advantageous properties and the potential to neutralize the virus. For identification and characterization of a broad spectrum of anti-SARS-CoV-2 Spike nanobodies, we further optimized a yeast display method, leveraging a previously published mass spectrometry-based method, using B-cell complementary DNA from the same immunized animals as a source of VHH sequences. Yeast display captured many of the sequences identified by the previous approach, as well as many additional sequences that proved to encode a large new repertoire of nanobodies with high affinities and neutralization activities against different SARS-CoV-2 variants. We evaluated DNA shuffling applied to the three complementarity-determining regions of antiviral nanobodies. The results suggested a surprising degree of modularity to complementarity-determining region function. Importantly, the yeast display approach applied to nanobody libraries from immunized animals allows parallel interrogation of a vast number of nanobodies. For example, we employed a modified yeast display to carry out massively parallel epitope binning. The current yeast display approach proved comparable in efficiency and specificity to the mass spectrometry-based approach, while requiring none of the infrastructure and expertise required for that approach, making these highly complementary approaches that together appear to comprehensively explore the paratope space. The larger repertoires produced maximize the likelihood of discovering broadly specific reagents and those that powerfully synergize in mixtures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Cell Cycle Genetics, The Rockefeller University, New York, New York, USA. Electronic address: fcross@rockefeller.edu.
- Laboratory of Cellular and Structural Biology, The Rockefeller University, New York, New York, USA.
- Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, USA.
- Laboratory of Cell Cycle Genetics, The Rockefeller University, New York, New York, USA.
- Laboratory of Mass Spectrometry and Gaseous Ion Chemistry, The Rockefeller University, New York, USA.
- Laboratory of Cellular and Structural Biology, The Rockefeller University, New York, New York, USA. Electronic address: rout@rockefeller.edu.
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- National Institutes of Health
- Rockefeller University
Zitieren
APA
Cross, F. R., Fridy, P. C., Ketaren, N. E., Mast, F. D., Li, S., Olivier, J. P., Pecani, K., Chait, B. T., Aitchison, J. D., & Rout, M. P. (2023). Expanding and improving nanobody repertoires using a yeast display method: Targeting SARS-CoV-2. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.102954
Vancouver
Cross FR, Fridy PC, Ketaren NE, Mast FD, Li S, Olivier JP, et al. Expanding and improving nanobody repertoires using a yeast display method: Targeting SARS-CoV-2. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.102954
BibTeX
@article{Cross2023,
author = {Cross, Frederick R and Fridy, Peter C and Ketaren, Natalia E and Mast, Fred D and Li, Song and Olivier, J Paul and Pecani, Kresti and Chait, Brian T and Aitchison, John D and Rout, Michael P},
title = {Expanding and improving nanobody repertoires using a yeast display method: Targeting SARS-CoV-2},
journal = {Journal of Biological Chemistry},
year = {2023},
doi = {10.1016/j.jbc.2023.102954}
}
EUVIMED